Business

Akoustis to Present at the Oppenheimer 25th Annual Technology, Internet & Communications Conference on August 9th from 12:25 pm to 1:05 pm ET

Charlotte, N.C., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ : AKTS) (“Akoustis” or the “Company”), an integrated device

articleAktis Oncology, Inc.August 8, 20223/company/aktis-oncology-inc-common-stock/news/akoustis-to-present-at-the-oppenheimer-25th-annual-technology-internet-communications
Akoustis to Present at the Oppenheimer 25th Annual Technology, Internet & Communications Conference on August 9th from 12:25 pm to 1:05 pm ET

About this update from Aktis Oncology, Inc.

[{"type":"text","content":"Charlotte, N.C., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ : AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today that senior management will present at the Oppenheimer 25th Annual Technology, Internet & Communications Conference on August 9th from 12:25 pm to 1:05 pm ET. The conference is being held virtually and senior management will be hosting one-on-one meetings. Investors that would like to schedule a meeting with management should contact their Oppenheimer representative or Akoustis’ investor relations at [email protected]. To access the webcast of the presentation, please use the following link: webcast. Akoustis is actively delivering volume production of its Wi-Fi 6 tandem filter solutions, shipping multiple 5G small cell XBAW® filter solutions, delivering initial designs of its new 5G mobile filter solutions to multiple customers and has entered the market with its new Wi-Fi 6E coexistence XBAW® filter solutions. To date, Akoustis has received more than 20 customer design wins for its patented XBAW® filter solutions. About Akoustis Technologies, Inc. Akoustis® (http://www.akoustis.com/) is a high-tech BAW RF filter solutions company that is pioneering next-generation materials science and MEMS wafer manufacturing to address the market requirements for improved RF filters - targeting higher bandwidth, higher operating frequencies and higher output power compared to incumbent polycrystalline BAW technology deployed today. The Company utilizes its proprietary and patented XBAW® manufacturing process to produce bulk acoustic wave RF filters for mobile and other wireless markets, which facilitate signal acquisition and accelerate band performance between the antenna and digital back end. Superior performance is driven by the significant advances of poly-crystal, high-purity and single-crystal piezoelectric materials and the resonator-filter process technology which enables optimal trade-offs between critical power, frequency and bandwidth performance specifications. Akoustis plans to service the fast growing multi-billion-dollar RF filter market using its integrated device manufacturer (IDM) business model. The Company owns and operates a 120,000 sq. ft. ISO...

More updates from Aktis Oncology, Inc.